Skip to main content
. 2020 Sep 8;20(5):202. doi: 10.3892/ol.2020.12065

Figure 4.

Figure 4.

Relapse free survival outcomes according to different BACE1-AS levels in different subgroups. Subgroups include tumor grades G1/G2, G3/G4, stage I/II, stage III/IV, males and females, younger and older patients. BACE1-AS, β-site APP-cleaving enzyme 1 antisense.